PD65-11 INCLUSION OF KLK3 GERMLINE NONSYNONYMOUS MUTATION I179T AS PART OF MULTIGENE PANEL TESTING FOR PREDICTING PROSTATE CANCER PROGRESSION

INTRODUCTION AND OBJECTIVE:Clinical guidelines now include germline testing for prostate cancer (PCa). Currently, only 11 genes are routinely evaluated for rare pathogenic mutations (RPMs). Common ...